EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Cancer-Associated Fibroblast-Targeted Nanomedicine in Solid Tumor Therapy: From Mechanisms of Therapeutic Resistance to Precision Stromal Modulation

Rong Wang, Zhongsong Zhang iD, Jiahui Du iD, Junhao Chen iD, Yuanyin Teng iD, Qi Wang iD, Zhu Wu, Ting Yang, Haiyan Jiang

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s603425 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Rong Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610550, People's Republic of China. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Nanomedicine, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer-Associated FibroblastsNanomedicineNeoplasmsHumansTumor MicroenvironmentAnimalsDrug Resistance, NeoplasmAntineoplastic Agents

Stichwörter der Autor:innen

cancer-associated fibroblastsextracellular matriximmunotherapynanomedicinesolid tumorsstromal modulationtherapeutic resistancetumor microenvironment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610550, People's Republic of China.
  • School of Clinical Medicine, Chengdu Medical College, Chengdu, 610550, People's Republic of China.
  • School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, 325000, People's Republic of China.
  • Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, 650032, People's Republic of China.
  • Institute of Hematology, Zhejiang University, Hangzhou, 310003, People's Republic of China.
  • The Hunan Provincial Key Laboratory of the TCM Agricultural Biogenomics, Changsha Medical University, Changsha, 410219, Hunan Province, People's Republic of China.

ORCID-Profile: Zhongsong Zhang, Jiahui Du, Junhao Chen, Yuanyin Teng, Qi Wang

Zitieren

APA

Wang, R., Zhang, Z., Du, J., Chen, J., Teng, Y., Wang, Q., Wu, Z., Yang, T., & Jiang, H. (2026). Cancer-Associated Fibroblast-Targeted Nanomedicine in Solid Tumor Therapy: From Mechanisms of Therapeutic Resistance to Precision Stromal Modulation. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s603425

Vancouver

Wang R, Zhang Z, Du J, Chen J, Teng Y, Wang Q, et al. Cancer-Associated Fibroblast-Targeted Nanomedicine in Solid Tumor Therapy: From Mechanisms of Therapeutic Resistance to Precision Stromal Modulation. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s603425

BibTeX
@article{Wang2026,
  author = {Wang, Rong and Zhang, Zhongsong and Du, Jiahui and Chen, Junhao and Teng, Yuanyin and Wang, Qi and Wu, Zhu and Yang, Ting and Jiang, Haiyan},
  title = {Cancer-Associated Fibroblast-Targeted Nanomedicine in Solid Tumor Therapy: From Mechanisms of Therapeutic Resistance to Precision Stromal Modulation},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s603425}
}
Kostenlos starten →